In August 2022, the ESC Conference held in Barcelona, Spain, released the latest results of DELIVER, PERSPECTIVE, ADVOR clinical trial about heart failure, bringing new concept of evidence-based medical treatment to the heart failure. Keywords: ESC express / heart failure / DELIVER trial 心力衰...
Traditionally, clinical treatment strategies have been approved based on average-population-benefit decisions derived from the randomized clinical trials of unselected patients, which were the cornerstone of traditional drug approvals. Tissue-of-origin trials are drug-centered, which refers to investigations...
While COVID-19 remains critically important, overall trends for new scientific studies reflect an increasing number of clinical trials being submitted from around the world in addition to those of North America. Large numbers of study subjects in imaging trials are now common. This results in more...
Alzheimer's disease (AD) is the leading cause of dementia, presenting a significant unmet medical need worldwide. The pathogenesis of AD involves various pathophysiological events, including the accumulation of amyloid and tau, neuro-inflammation, and ne
海外New Things｜IMA收购Clinical Trials of America完成，拓展临床研究规模和多样性 文 | 邢颖 IMA集团于1月11日宣布已完成对Clinical Trials of America（CTA）的收购，该公司为IMA带来了位于路易斯安那州和北卡罗来纳州的四个新的独立站点和六个嵌入式站点。总部位于洛杉矶门罗的CTA将继续运营，其现有的领导层，...
Clinical trials are a traditional ways to determine the safety and efficiency of a drug or a medical device, or any other therapeutic product.
As clinical trials become more and more decentralised, technology and experience can support a cross-functional project team to identify potential issues. This will reduce the likelihood of missing risks. Planning, through an intelligent technology application, is part of the solution and a key factor...
Insmed Incorporated (Nasdaq:INSM) today announced that eight presentations across three of its pillars—ARIKAYCE® (amikacin liposome inhalation suspension), brensocatib, and treprostinil palmitil inhalation powder (TP...
Clinical trials of compounds like psilocybin have yielded plenty of impressive results over the past several years, and those findings can now be molded into proper conformity with FDA guidance to bolster commercialization efforts.In January, MRP noted that a successful phase 2B trial of psilocybin ...
IMA集团于1月11日宣布已完成对Clinical Trials of America(CTA)的收购,该公司为IMA带来了位于路易斯安那州和北卡罗来纳州的四个新的独立站点和六个嵌入式站点。 总部位于洛杉矶门罗的CTA将继续运营,其现有的领导层,调查人员和工作人员将继续留在原部门,由其前首席执行官兼总裁Jeb Andrews博士领导,交易条款未披露。